Pharmaceuticals News and Research

RSS
Lexicon Pharmaceuticals announces clinical trial, mechanistic study results of LX4211

Lexicon Pharmaceuticals announces clinical trial, mechanistic study results of LX4211

6 Jan 2011
Symphogen closes €100 million stock to a group of investors

Symphogen closes €100 million stock to a group of investors

6 Jan 2011
Medical experts issue warning about common practice of tablet splitting

Medical experts issue warning about common practice of tablet splitting

6 Jan 2011
Findings of AM095 in various in vitro, in vivo models of fibrotic disease published in JPET

Findings of AM095 in various in vitro, in vivo models of fibrotic disease published in JPET

6 Jan 2011
Studies show XIFAXAN 550 mg tablets demonstrate significant relief of global IBS symptoms

Studies show XIFAXAN 550 mg tablets demonstrate significant relief of global IBS symptoms

6 Jan 2011
J&JPRD submits New Drug Application to FDA for rivaroxaban

J&JPRD submits New Drug Application to FDA for rivaroxaban

6 Jan 2011
Indian drugmaker seeks to make, sell generic version of Pfizer's HIV drug

Indian drugmaker seeks to make, sell generic version of Pfizer's HIV drug

6 Jan 2011
Positive topline results from ZGN-433 Phase 1b study in obesity patients

Positive topline results from ZGN-433 Phase 1b study in obesity patients

6 Jan 2011
Insite Vision announces completion of patient enrollment in ISV-303 Phase 1/2 trial for post surgical ocular pain, inflammation

Insite Vision announces completion of patient enrollment in ISV-303 Phase 1/2 trial for post surgical ocular pain, inflammation

6 Jan 2011
Water Street Healthcare announces acquisition of OraPharma from Johnson & Johnson

Water Street Healthcare announces acquisition of OraPharma from Johnson & Johnson

6 Jan 2011
Spectrum Pharmaceuticals enters agreement with Viropro to develop biosimilar rituximab

Spectrum Pharmaceuticals enters agreement with Viropro to develop biosimilar rituximab

5 Jan 2011
Teva acquires Théramex

Teva acquires Théramex

5 Jan 2011
Tablet splitting leads to inaccurate dosages

Tablet splitting leads to inaccurate dosages

5 Jan 2011
KINAXO, AstraZeneca enter oncology research collaboration

KINAXO, AstraZeneca enter oncology research collaboration

5 Jan 2011
EUSA receives FDA Priority Review status for ERWINAZE BLA

EUSA receives FDA Priority Review status for ERWINAZE BLA

5 Jan 2011
arGEN-X's alliance with Lilly highlights potential of SIMPLE Antibody platform

arGEN-X's alliance with Lilly highlights potential of SIMPLE Antibody platform

5 Jan 2011
Alkeus and Columbia University enter license agreement for potential therapies for dry-AMD, Stargardt disease

Alkeus and Columbia University enter license agreement for potential therapies for dry-AMD, Stargardt disease

5 Jan 2011
ReproCELL to enter collaborative iPS cell-derived hepatocytes R&D agreement with NIBIO

ReproCELL to enter collaborative iPS cell-derived hepatocytes R&D agreement with NIBIO

5 Jan 2011
Indian government rejects Abbott's patent application for second-line ARV

Indian government rejects Abbott's patent application for second-line ARV

5 Jan 2011
DBV Technologies secures $25.5 million in Series C financing round

DBV Technologies secures $25.5 million in Series C financing round

5 Jan 2011

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback